Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02393118` - A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury	N/A
Terminated	`NCT00262509` - Emergency Egress and Information System for Persons With Vision Loss	N/A
Terminated	`NCT00691444` - Blind Child Melatonin Treatment Study	N/A
Recruiting	`NCT06237829` - Testing Tactile Aids With Blind Subjects	N/A
Completed	`NCT00829036` - Wayfinding Information Access System for People With Vision Loss	N/A
Completed	`NCT02643238` - Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation	N/A
Completed	`NCT01488786` - A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind	N/A
Recruiting	`NCT00403143` - Do Blue-Blocking Lenses Block Blue Colour From Our Lives?	N/A
Recruiting	`NCT06451172` - Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis	Early Phase 1
Recruiting	`NCT02983370` - Development of a Cortical Visual Neuroprosthesis for the Blind	N/A
Not yet recruiting	`NCT06070467` - Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases
Completed	`NCT01109576` - Workshops for Veterans With Vision and Hearing Loss	Phase 0
Completed	`NCT00920231` - Computer Vision System for the Blind Veteran	Phase 1
Terminated	`NCT00795236` - Melatonin Studies of Totally Blind Children	N/A
Terminated	`NCT00634972` - Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity	Phase 4
Enrolling by invitation	`NCT06364605` - MySpace: the Role of Vision in Representing Space	N/A
Terminated	`NCT03913130` - Extension Study to Study PQ-110-001 (NCT03140969)	Phase 1/Phase 2
Not yet recruiting	`NCT05806684` - Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
Completed	`NCT03753893` - Ocular Manifestations in Rheumatic Diseases
Recruiting	`NCT04855045` - An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.	Phase 2/Phase 3

NCT number	NCT04725760
Study type	Interventional
Source	Wicab
Contact	Patricia Grant, Ph.D.
Phone	312-447-3234
Email	pgrant@wicab.com
Status	Recruiting
Phase	N/A
Start date	October 1, 2020
Completion date	September 30, 2022

Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance of Daily Activities in the Profoundly Blind French Population

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms